Evaluation of Resectability of Pancreatic Cancer Using Low kVp CT

Usefulness of Low kVp High mAs Computed Tomography for the Evaluation of Pancreatic Cancer Resectability

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03895177

Enrollment

147

Registered

2019-03-29

Start date

2019-03-12

Completion date

2022-01-31

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnoses Disease

Brief summary

The aim of this study is to investigate usefulness of low kVp high mAs computed tomography in evaluation of pancreatic cancer resectability.

Interventions

DIAGNOSTIC_TESTcontrast enhanced computed tomography

pancreatic protocol CT with 80kVp tube voltage and more than 500mA tube current acquire late arterial phase and portal venous phase using volus tracking method

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 85 Years

Healthy volunteers

Inclusion criteria

* 1\. age between 20 year-old and 85 year-old 2. patient with pancreatic cancer detected on standard CT scan using 120 kVp that obtained within one month 3. consider surgical resection for pancreatic cancer treatment 4. patients who can undergo contrast enhanced CT scan

Exclusion criteria

* 1\. history of severe adverse reaction to iodine contrast 2. less than 60 of estimated GFR

Design outcomes

Primary

Measure	Time frame	Description
accuracy of low kVp CT to assess R0 resection of pancreatic cancer	2 weeks after surgery	Pancreastic cancer resectability

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026